182781842	182781842	CD	B-NP	O
|	|	NN	I-NP	O
DGMC	DGMC	NN	I-NP	O
|	|	NN	I-NP	O
49695934	49695934	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1939515	1939515	CD	B-NP	O
|	|	CC	I-NP	O
10/10/2006	10/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Gout	Gout	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/27/2006	2/27/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/26/2006	3/26/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
PIZZI	PIZZI	NNP	B-NP	O
,	,	,	O	O
CLAYTON	CLAYTON	NNP	B-NP	O
550-19-26-3	550-19-26-3	CD	I-NP	O
Clemensshire	Clemensshire	NNP	I-NP	O
Highway	Highway	NNP	I-NP	O
,	,	,	O	O
Son	Son	NNP	B-NP	O
Pae	Pae	NNP	I-NP	O
,	,	,	O	O
New	New	NNP	B-NP	O
Hampshire	Hampshire	NNP	I-NP	O
98620	98620	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/3/06	2/3/06	CD	B-NP	O
AT	AT	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BERTO	BERTO	NNP	B-NP	O
,	,	,	O	O
AURELIO	AURELIO	NNP	B-NP	O
AHMED	AHMED	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
COLCHICINE	COLCHICINE	NNP	I-NP	O
0.6	0.6	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
q	q	NN	I-NP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
Starting	Starting	NNP	B-NP	O
Today	Today	NNP	I-NP	O
August	August	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/7/06	10/7/06	CD	B-NP	O
by	by	IN	B-PP	O
LEGATH	LEGATH	NN	B-NP	O
,	,	,	O	O
FOREST	FOREST	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	B-protein
aware	aware	JJ	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
IRON	IRON	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
August	August	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Avoid	Avoid	NNP	I-NP	I-protein
milk	milk	NN	I-NP	I-protein
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
75	75	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/7/06	10/7/06	CD	B-NP	O
by	by	IN	B-PP	O
KROPP	KROPP	NN	B-NP	B-protein
,	,	,	O	O
LEROY	LEROY	NNP	B-NP	O
R	R	NNP	I-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
909904507	909904507	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/16/06	6/16/06	CD	B-NP	O
by	by	IN	B-PP	O
CACAL	CACAL	NNP	B-NP	O
,	,	,	O	O
CEDRIC	CEDRIC	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
145736638	145736638	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
DENICK	DENICK	NNP	B-NP	O
,	,	,	O	O
DEANDRE	DEANDRE	NNP	B-NP	O
R	R	NNP	I-NP	O
BARRY	BARRY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
458699516	458699516	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
REGLAN	REGLAN	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
METOCLOPRAMIDE	METOCLOPRAMIDE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
August	August	NNP	I-NP	I-protein
OXYCODONE	OXYCODONE	NNP	I-NP	I-protein
5-10	5-10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q6H	Q6H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
oversedated	oversedate	VBD	B-VP	O
SENNA	SENNA	NNP	B-NP	O
TABLETS	TABLETS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SENNOSIDES	SENNOSIDES	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	B-DNA
PO	PO	NN	I-NP	I-DNA
BID	BID	NN	I-NP	I-DNA
THIAMINE	THIAMINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
QD	QD	NN	I-NP	I-DNA
TRAZODONE	TRAZODONE	NN	I-NP	I-DNA
50	50	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
HS	HS	NNP	I-NP	I-DNA
PRN	PRN	NNP	I-NP	I-DNA
Insomnia	Insomnia	NNP	I-NP	I-DNA
COUMADIN	COUMADIN	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
WARFARIN	WARFARIN	NNP	I-NP	I-DNA
SODIUM	SODIUM	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
4	4	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
NOW	NOW	NNP	I-NP	I-DNA
August	August	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
Except	Except	IN	B-PP	O
on	on	IN	B-PP	O
Wednesdays	Wednesday	NNS	B-NP	O
and	and	CC	I-NP	O
Saturdays	Saturday	NNS	I-NP	O
,	,	,	O	O
adjusted	adjust	VBN	B-VP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
MCH	MCH	NNP	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
instruction	instruction	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/16/06	6/16/06	CD	B-NP	O
by	by	IN	B-PP	O
DEBUTIACO	DEBUTIACO	NNP	B-NP	O
,	,	,	O	O
DARIO	DARIO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
DESANTIAGO	DESANTIAGO	NNP	B-NP	O
,	,	,	O	O
DARELL	DARELL	NNP	B-NP	O
TYRELL	TYRELL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
August	August	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
NEURONTIN	NEURONTIN	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
200	200	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
K-DUR	K-DUR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
COMC	COMC	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	B-protein
TORSEMIDE	TORSEMIDE	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
August	August	NNP	I-NP	I-protein
COZAAR	COZAAR	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LOSARTAN	LOSARTAN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
August	August	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
LEVOCARNITINE	LEVOCARNITINE	NN	I-NP	O
1	1	CD	B-NP	O
GM	GM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
CELEXA	CELEXA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
August	August	NNP	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
ADVAIR	ADVAIR	NN	I-NP	O
DISKUS	DISKUS	VBZ	B-VP	O
250/50	250/50	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LANTUS	LANTUS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
58	58	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ON	ON	NNP	I-NP	O
5/14/07	5/14/07	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	B-protein
NOVOLOG	NOVOLOG	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
ASPART	ASPART	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
6	6	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
AC	AC	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
August	August	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
24	24	CD	I-NP	I-protein
h	h	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
dose	dose	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/3/06	2/3/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
PRN	PRN	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/3/06	2/3/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
CALCITRIOL	CALCITRIOL	NN	I-NP	O
0.25	0.25	CD	I-NP	O
MCG	MCG	NN	I-NP	O
PO	PO	NN	I-NP	O
3x/Week	3x/Week	NN	I-NP	O
M-W-F	M-W-F	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
Wednesdays	Wednesday	NNS	B-NP	O
and	and	CC	I-NP	O
Saturdays	Saturday	NNS	I-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/3/06	2/3/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
METOLAZONE	METOLAZONE	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
on	on	IN	B-PP	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
Saturday	Saturday	NNP	B-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Give	Give	VB	B-VP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
prior	prior	JJ	B-NP	O
torsemide	torsemide	NN	I-NP	O
NEXIUM	NEXIUM	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
SIMETHICONE	SIMETHICONE	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
DR	DR	NNP	B-NP	O
GLOECKLER	GLOECKLER	NNP	I-NP	O
RTH	RTH	NNP	I-NP	O
Flint	Flint	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
843	843	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
453-3147	453-3147	CD	I-NP	O
2/10/06	2/10/06	CD	I-NP	O
@	@	SYM	B-NP	O
2	2	CD	I-NP	O
:	:	SYM	I-NP	O
10	10	CD	I-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
DR	DR	NN	B-NP	O
WINCHESTER	WINCHESTER	NN	I-NP	O
10/12/06	10/12/06	CD	I-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
AM	AM	VBP	B-VP	O
scheduled	scheduled	JJ	B-ADJP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
6/20/06	6/20/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
14	14	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
MCH	MCH	NNP	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
SHRIMP	SHRIMP	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
hand	hand	NN	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gout	Gout	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Adriamycin	Adriamycin	NN	I-NP	O
induced	induce	VBD	B-VP	O
CMP	CMP	NN	B-NP	O
HTN	HTN	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
Sarcoid	Sarcoid	JJ	I-NP	O
Left	Left	NN	I-NP	O
Breast	Breast	NN	I-NP	O
CA	CA	NN	I-NP	O
-	-	HYPH	B-NP	O
s/p	s/p	NN	I-NP	O
lumpect	lumpect	NN	I-NP	O
and	and	CC	I-NP	O
XRT/Adria	XRT/Adria	NN	I-NP	O
-	-	HYPH	B-NP	O
'84	'84	CD	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
?	?	.	O	O

GI	GI	NN	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
pain	pain	NN	I-NP	O
dvt	dvt	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
unspecified	unspecified	JJ	I-NP	O
or	or	CC	I-NP	O
generalized	generalize	VBN	I-NP	O
OA	OA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroid	hypothyroid	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
left	left	JJ	B-NP	O
hand	hand	NN	I-NP	O
swelling	swell	VBG	B-VP	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
61yoF	61yoF	NN	B-NP	O
with	with	IN	B-PP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
h/o	h/o	NN	I-NP	O
dvt	dvt	NN	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
right	right	JJ	I-NP	O
mastectomy	mastectomy	NN	I-NP	O
for	for	IN	B-PP	O
DCIS	DCIS	NNS	B-NP	B-protein
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
hand	hand	NN	I-NP	O
erythema	erythema	NN	I-NP	O
and	and	CC	O	O
welling	welling	NN	B-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
started	start	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
thumb	thumb	NN	I-NP	O
and	and	CC	O	O
spread	spread	VBN	B-VP	O
to	to	TO	I-VP	O
wrist	wrist	VB	I-VP	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
DIP	DIP	NN	B-NP	B-protein
,	,	,	O	O
MCP	MCP	NN	B-NP	O
of	of	IN	B-PP	O
first	first	JJ	B-NP	O
finger	finger	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
pain/tenderness	pain/tenderness	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
elbow	elbow	NN	I-NP	O
.	.	.	O	O

DM	DM	NN	B-NP	O
control	control	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
poor	poor	JJ	B-ADJP	O
since	since	IN	B-SBAR	O
sx	sx	NN	B-NP	O
started	start	VBD	B-VP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
trauma	trauma	NN	I-NP	O
,	,	,	O	O
bites	bite	NNS	B-NP	O
,	,	,	O	O
cuts	cut	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
f/c	f/c	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
anorexia/n/v	anorexia/n/v	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
writted	writte	VBN	B-VP	O
for	for	IN	B-PP	O
nafcillin	nafcillin	NN	B-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
AICD	AICD	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
COPD	COPD	NN	B-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
mastectomy	mastectomy	NN	I-NP	O
All	All	DT	B-NP	O
:	:	:	O	O
shrimp	shrimp	VB	B-VP	O
SH	SH	NN	B-NP	O
:	:	:	O	O
lives	life	NNS	B-NP	O
in	in	IN	B-PP	O
assisted	assist	VBN	B-NP	O
living	living	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tob/etoh/drugs	tob/etoh/drug	NNS	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
T97	T97	NN	B-NP	O
.7	.7	NN	I-NP	O
,	,	,	O	O
hr80	hr80	NN	B-NP	B-protein
,	,	,	O	O
bp95/62	bp95/62	NN	B-NP	O
,	,	,	O	O
r20	r20	NN	B-NP	B-protein
,	,	,	O	O
sat100	sat100	CD	B-NP	O
%	%	NN	I-NP	O
ra	ra	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
aox3	aox3	NN	B-NP	O
,	,	,	O	O
speaks	speak	VBZ	B-VP	O
slowly	slowly	RB	B-ADVP	O
,	,	,	O	O
nad	nad	NN	B-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
h/n	h/n	NN	I-NP	O
:	:	:	O	O
perrl	perrl	NN	B-NP	O
,	,	,	O	O
eomi	eomi	NN	B-NP	O
,	,	,	O	O
mmm	mmm	NN	B-NP	O
,	,	,	O	O
jvp	jvp	NN	B-NP	O
7cm	7cm	NN	I-NP	O
water	water	NN	I-NP	O
Chest	Chest	NNP	I-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
right	right	JJ	B-NP	O
mast	mast	NN	I-NP	O
scar	scar	NN	I-NP	O
Cor	Cor	NNP	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
nl	nl	NN	I-NP	I-protein
s1s2	s1s2	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
mrg	mrg	NN	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
ntnd	ntnd	NN	I-NP	O
,	,	,	O	O
nabs	nab	NNS	B-NP	O
ext	ext	VBP	B-VP	O
:	:	:	O	O
swollen	swell	VBN	B-NP	O
ankle	ankle	NN	I-NP	O
nonpitting	nonpitting	JJ	B-ADJP	O
,	,	,	O	O
tender	tender	NN	B-NP	O
over	over	IN	B-PP	O
left	left	JJ	B-NP	O
hand	hand	NN	I-NP	O
DIPS	DIPS	NN	I-NP	O
,	,	,	O	O
1st/2nd	1st/2nd	NN	B-NP	O
MCPs	MCP	NNS	I-NP	O
,	,	,	O	O
elbow	elbow	NN	B-NP	O
pain	pain	NN	I-NP	O
w/active	w/active	JJ	I-NP	O
movt	movt	NN	I-NP	O
Xray	Xray	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
swelling	swelling	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
wrist	wrist	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
effusion	effusion	NN	I-NP	O
no	no	DT	B-NP	O
fracture	fracture	NN	I-NP	B-protein
Labs	Lab	NNS	I-NP	I-protein
:	:	:	O	O
Cr	Cr	NN	B-NP	O
2.3	2.3	CD	I-NP	O
,	,	,	O	O
Gluc	Gluc	NN	B-NP	B-protein
442	442	CD	I-NP	I-protein
,	,	,	O	O
dimer	dimer	NN	B-NP	O
394	394	CD	I-NP	O
,	,	,	O	O
wbc	wbc	NN	B-NP	B-protein
7.4	7.4	CD	I-NP	I-protein
,	,	,	O	O
hct	hct	NN	B-NP	O
39	39	CD	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
with	with	IN	B-PP	O
1deg	1deg	NN	B-NP	O
avb	avb	NN	I-NP	O
at	at	IN	B-PP	O
73bpm	73bpm	NN	B-NP	O
,	,	,	O	O
old	old	JJ	B-NP	O
antlat	antlat	NN	I-NP	O
infarction	infarction	NN	I-NP	O
****************	****************	SYM	B-NP	O
Hospital	Hospital	NN	I-NP	O
Course	Course	NN	I-NP	O
******************	******************	SYM	B-NP	O
61yoF	61yoF	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
polyarthritis	polyarthritis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
hand/wrist	hand/wrist	NN	I-NP	O
with	with	IN	B-PP	O
overlying	overlie	VBG	B-VP	O
swelling	swelling	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
illness	illness	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
is	be	VBZ	B-VP	O
gout	gout	VBN	I-VP	O
,	,	,	O	O
given	give	VBN	B-PP	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
signs	sign	NNS	I-NP	O
or	or	CC	O	O
risk	risk	NN	B-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
septic	septic	JJ	B-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

RHEUM	RHEUM	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
refused	refuse	VBD	B-VP	O
left	left	JJ	B-NP	O
wrist	wrist	NN	I-NP	O
tap	tap	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
by	by	IN	B-PP	O
rheumatology	rheumatology	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
starting	start	VBG	I-VP	O
steroids	steroid	NNS	B-NP	O
and	and	CC	O	O
continuing	continue	VBG	B-NP	O
colchicine	colchicine	NN	I-NP	O
for	for	IN	B-PP	O
sx	sx	NN	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
0.6	0.6	CD	B-NP	O
mg	mg	NN	I-NP	O
qod	qod	NN	I-NP	O
given	give	VBN	B-VP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
to	to	TO	B-VP	O
finish	finish	VB	I-VP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
steroid	steroid	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
hand	hand	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
was	be	VBD	B-VP	O
mildly	mildly	RB	I-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
septic	septic	JJ	B-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
at	at	IN	B-PP	O
2.3	2.3	CD	B-NP	O
near	near	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
renally	renally	RB	B-ADVP	O
dose	dose	NN	B-NP	O
medications	medication	NNS	I-NP	O
5	5	CD	B-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
hyperglycemia	hyperglycemia	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
HONK	HONK	NN	B-NP	B-protein
,	,	,	O	O
likely	likely	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

Hyperglycemia	Hyperglycemia	NN	B-NP	O
was	be	VBD	B-VP	O
further	further	RBR	I-VP	O
worsened	worsen	VBN	I-VP	O
by	by	IN	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
expected	expect	VBN	B-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
's	's	POS	B-NP	O
insulin	insulin	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
were	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
and	and	CC	O	O
standing	stand	VBG	B-VP	O
novolog	novolog	NN	B-NP	O
increased	increase	VBD	B-VP	O
qAC	qAC	NN	B-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
under	under	IN	B-PP	O
improved	improve	VBN	B-NP	O
control	control	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
lantus/novolog	lantus/novolog	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
written	write	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
VNA	VNA	NN	B-NP	B-protein
to	to	TO	B-VP	O
help	help	VB	I-VP	O
her	her	PRP	B-NP	O
with	with	IN	B-PP	O
glucose	glucose	NN	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

Thyroid	Thyroid	JJ	B-NP	O
replacement	replacement	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
Please	Please	NN	I-NP	O
note	note	NN	I-NP	O
,	,	,	O	O
medication	medication	NN	B-NP	O
list	list	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
verified	verify	VBN	I-VP	O
against	against	IN	B-PP	O
medications	medication	NNS	B-NP	O
list	list	NN	I-NP	O
administered	administer	VBN	B-VP	O
by	by	IN	B-PP	O
Naa	Naa	NNP	B-NP	O
/	/	SYM	O	O
Oim	Oim	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
updated	update	VBN	I-VP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
what	what	WP	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
receiving	receive	VBG	I-VP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
seek	seek	VBP	B-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
hand	hand	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
300	300	CD	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
all	all	DT	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
one	one	CD	B-NP	O
new	new	JJ	I-NP	O
medication	medication	NN	I-NP	O
:	:	:	O	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
10mg	10mg	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
2	2	CD	I-NP	O
pills	pill	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
5mg	5mg	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
pill	pill	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
stop	stop	VB	B-VP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
administer	administer	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
sheet	sheet	NN	B-NP	O
given	give	VBN	B-VP	O
to	to	TO	B-PP	O
you	you	PRP	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Check	Check	VB	B-VP	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
before	before	IN	B-PP	O
each	each	DT	B-NP	O
meal	meal	NN	I-NP	O
and	and	CC	O	O
apply	apply	VB	B-VP	O
sliding	slide	VBG	I-VP	O
scale	scale	NN	B-NP	O
per	per	IN	B-PP	O
handout	handout	NN	B-NP	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
reading	reading	NN	I-NP	O
>	>	SYM	B-NP	O
250-300	250-300	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
GEESEY	GEESEY	NNP	B-NP	O
,	,	,	O	O
ERIC	ERIC	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CB420	CB420	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/3/06	2/3/06	CD	I-NP	O
@	@	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
09	09	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

